273 related articles for article (PubMed ID: 27592803)
21. Development of a 3D cell printed construct considering angiogenesis for liver tissue engineering.
Lee JW; Choi YJ; Yong WJ; Pati F; Shim JH; Kang KS; Kang IH; Park J; Cho DW
Biofabrication; 2016 Jan; 8(1):015007. PubMed ID: 26756962
[TBL] [Abstract][Full Text] [Related]
22. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
[TBL] [Abstract][Full Text] [Related]
24. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
[TBL] [Abstract][Full Text] [Related]
25. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
[TBL] [Abstract][Full Text] [Related]
26. Latest impact of engineered human liver platforms on drug development.
Monckton CP; Brown GE; Khetani SR
APL Bioeng; 2021 Sep; 5(3):031506. PubMed ID: 34286173
[TBL] [Abstract][Full Text] [Related]
27. Microprinting of liver micro-organ for drug metabolism study.
Chang RC; Emami K; Jeevarajan A; Wu H; Sun W
Methods Mol Biol; 2011; 671():219-38. PubMed ID: 20967633
[TBL] [Abstract][Full Text] [Related]
28. Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans.
Atienzar FA; Novik EI; Gerets HH; Parekh A; Delatour C; Cardenas A; MacDonald J; Yarmush ML; Dhalluin S
Toxicol Appl Pharmacol; 2014 Feb; 275(1):44-61. PubMed ID: 24333257
[TBL] [Abstract][Full Text] [Related]
29. Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering.
Du C; Narayanan K; Leong MF; Wan AC
Biomaterials; 2014 Jul; 35(23):6006-14. PubMed ID: 24780169
[TBL] [Abstract][Full Text] [Related]
30. Long-term maintenance of a microfluidic 3D human liver sinusoid.
Prodanov L; Jindal R; Bale SS; Hegde M; McCarty WJ; Golberg I; Bhushan A; Yarmush ML; Usta OB
Biotechnol Bioeng; 2016 Jan; 113(1):241-6. PubMed ID: 26152452
[TBL] [Abstract][Full Text] [Related]
31. Endosteal-like extracellular matrix expression on melt electrospun written scaffolds.
Muerza-Cascante ML; Shokoohmand A; Khosrotehrani K; Haylock D; Dalton PD; Hutmacher DW; Loessner D
Acta Biomater; 2017 Apr; 52():145-158. PubMed ID: 28017869
[TBL] [Abstract][Full Text] [Related]
32. Dynamic culture yields engineered myocardium with near-adult functional output.
Jackman CP; Carlson AL; Bursac N
Biomaterials; 2016 Dec; 111():66-79. PubMed ID: 27723557
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
[TBL] [Abstract][Full Text] [Related]
34. In vitro platforms for evaluating liver toxicity.
Bale SS; Vernetti L; Senutovitch N; Jindal R; Hegde M; Gough A; McCarty WJ; Bakan A; Bhushan A; Shun TY; Golberg I; DeBiasio R; Usta BO; Taylor DL; Yarmush ML
Exp Biol Med (Maywood); 2014 Sep; 239(9):1180-1191. PubMed ID: 24764241
[TBL] [Abstract][Full Text] [Related]
35. An integrated experimental-computational approach for the study of engineered cartilage constructs subjected to combined regimens of hydrostatic pressure and interstitial perfusion.
Moretti M; Freed LE; Padera RF; Laganà K; Boschetti F; Raimondi MT
Biomed Mater Eng; 2008; 18(4-5):273-8. PubMed ID: 19065033
[No Abstract] [Full Text] [Related]
36. Advances in Engineered Human Liver Platforms for Drug Metabolism Studies.
Underhill GH; Khetani SR
Drug Metab Dispos; 2018 Nov; 46(11):1626-1637. PubMed ID: 30135245
[TBL] [Abstract][Full Text] [Related]
37. Thinking inside the box: keeping tissue-engineered constructs in vitro for use as preclinical models.
Gibbons MC; Foley MA; Cardinal KO
Tissue Eng Part B Rev; 2013 Feb; 19(1):14-30. PubMed ID: 22800715
[TBL] [Abstract][Full Text] [Related]
38. Hetero-cellular prototyping by synchronized multi-material bioprinting for rotary cell culture system.
Snyder J; Son AR; Hamid Q; Wu H; Sun W
Biofabrication; 2016 Jan; 8(1):015002. PubMed ID: 26759993
[TBL] [Abstract][Full Text] [Related]
39. Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research.
Bierwolf J; Lutgehetmann M; Feng K; Erbes J; Deichmann S; Toronyi E; Stieglitz C; Nashan B; Ma PX; Pollok JM
Biotechnol Bioeng; 2011 Jan; 108(1):141-50. PubMed ID: 20824672
[TBL] [Abstract][Full Text] [Related]
40. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture.
Lee PJ; Hung PJ; Lee LP
Biotechnol Bioeng; 2007 Aug; 97(5):1340-6. PubMed ID: 17286266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
